A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV)
Condition(s):Leptomeningeal Disease; Triple Negative Breast Cancer; HER2-positive Breast CancerLast Updated:April 13, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Leptomeningeal Disease; Triple Negative Breast Cancer; HER2-positive Breast CancerLast Updated:April 13, 2023Recruiting
Condition(s):Neuroendocrine Tumor Grade 2; Neuroendocrine Tumor Grade 1Last Updated:April 18, 2023Enrolling by invitation
Condition(s):ARDS, HumanLast Updated:February 1, 2023Active, not recruiting
Condition(s):Multiple MyelomaLast Updated:July 30, 2021Completed
Condition(s):Gastrointestinal Stromal Tumor (GIST); Digestive System Disease; Gastrointestinal Diseases; Metastatic CancerLast Updated:January 18, 2023Recruiting
Condition(s):Anti-MAG NeuropathyLast Updated:October 15, 2021Terminated
Condition(s):Breast Cancer; Gynecologic Cancer; HNSCC; Solid Tumors, AdultLast Updated:April 4, 2023Recruiting
Condition(s):Degenerative Spondylolisthesis; Spinal StenosisLast Updated:February 2, 2023Active, not recruiting
Condition(s):Solid Tumor, Adult; Hematopoietic/Lymphoid CancerLast Updated:October 6, 2022Recruiting
Condition(s):Mitral Valve RegurgitationLast Updated:March 3, 2021Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.